Evidence map›Paper›PMID 42012947›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Paramyxovirus infection driven by heteromultivalent sialoglycotope binding.

Xuesheng Wu, Mengying Liu, Laura Blekkenhorst, Mare H L Verbruggen, Nancy N M P Schuurman, Lemeng Chao, Jun Yang Ong, Tom Wennekes, Laura L A van Dijk, Rory D de Vries and 5 more

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Substitutions affecting the HA-NA-receptor balance preceded the emergence of the pandemic 2009 H1N1 virus.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Xuesheng WuSection Virology, Division Infectious Diseases and Immunology, Department Biomolecular Health Sciences, Faculty Veterinary Medicine, Utrecht University, Utrecht 3584CL, the Netherlands.ORCID 0000-0001-8136-1446
Mengying LiuSection Virology, Division Infectious Diseases and Immunology, Department Biomolecular Health Sciences, Faculty Veterinary Medicine, Utrecht University, Utrecht 3584CL, the Netherlands.
Laura BlekkenhorstSection Virology, Division Infectious Diseases and Immunology, Department Biomolecular Health Sciences, Faculty Veterinary Medicine, Utrecht University, Utrecht 3584CL, the Netherlands.
Mare H L VerbruggenSection Virology, Division Infectious Diseases and Immunology, Department Biomolecular Health Sciences, Faculty Veterinary Medicine, Utrecht University, Utrecht 3584CL, the Netherlands.
Nancy N M P SchuurmanSection Virology, Division Infectious Diseases and Immunology, Department Biomolecular Health Sciences, Faculty Veterinary Medicine, Utrecht University, Utrecht 3584CL, the Netherlands.
Lemeng ChaoDepartment Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht 3584CG, the Netherlands.
Jun Yang OngDepartment Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht 3584CG, the Netherlands.ORCID 0000-0002-0498-0689
Tom WennekesDepartment Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht 3584CG, the Netherlands.ORCID 0000-0002-2368-7728
Laura L A van DijkDepartment of Viroscience, Erasmus University Medical Center, Rotterdam 3015GD, the Netherlands.
Rory D de VriesDepartment of Viroscience, Erasmus University Medical Center, Rotterdam 3015GD, the Netherlands.ORCID 0000-0003-2817-0127
Frank J M van KuppeveldSection Virology, Division Infectious Diseases and Immunology, Department Biomolecular Health Sciences, Faculty Veterinary Medicine, Utrecht University, Utrecht 3584CL, the Netherlands.
Henrik ClausenCopenhagen Center for Glycomics, Departments of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark.ORCID 0000-0002-0915-5055
Yoshiki NarimatsuCopenhagen Center for Glycomics, Departments of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark.ORCID 0000-0003-1428-5695
Erik de VriesSection Virology, Division Infectious Diseases and Immunology, Department Biomolecular Health Sciences, Faculty Veterinary Medicine, Utrecht University, Utrecht 3584CL, the Netherlands.
Cornelis A M de HaanSection Virology, Division Infectious Diseases and Immunology, Department Biomolecular Health Sciences, Faculty Veterinary Medicine, Utrecht University, Utrecht 3584CL, the Netherlands.ORCID 0000-0002-4459-9874

Funding

China Scholarship Council (CSC) 202006010036Novo Nordisk Fonden (NNF) NNF21OC0071658Novo Nordisk Fonden (NNF) NNF24OC0088218ZonMw (Netherlands Organisation for Health Research and Development) 10710022210003
6 · The paper itself

Abstract

Sialic acids (Sia) on glycoproteins and glycosphingolipids act as receptors for many respiratory viruses, including human influenza A viruses and respiroviruses, which typically bind to α2-6- and α2-3-linked Sia (2-6Sia and 2-3Sia), respectively. In view of this binding discrepancy and as the exact sialoglycoconjugates supporting respirovirus infection remain unclear, we assessed the receptor requirements for infection and binding of several respiroviruses and avian Newcastle disease virus (NDV). To this end, we employed a library of isogenic HEK293 cells displaying defined sialoglycoconjugates. Respirovirus infection was shown to strictly depend on 2-3Sia, with a preference for the terminal Siaα2-3Galβ1-4GlcNAc sialoglycotope regardless of the underlying glycoconjugate structure, whereas NDV showed a broader sialoglycotope usage. Notably, 2-6Sia enhanced respirovirus infection in low 2-3Sia contexts via heteromultivalent surface binding, which resulted in prolonged virus-receptor interactions. This heteromultivalent binding is expected to aid respirovirus infection of the 2-6Sia-rich human upper respiratory tract.

Indexed as

Paramyxoviridae InfectionsReceptors, VirusRespirovirusSialic AcidsAnimalsHEK293 CellsHumansN-Acetylneuraminic AcidNewcastle disease virusProtein BindingVirus AttachmentN-Acetylneuraminic AcidReceptors, VirusSialic Acidsheteromultivalentparamyxovirusreceptorsialic acid

Identifiers

PMID42012947
PMCPMC13123808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.